Facrbook
Follow @eaonc
Youtube
  • Home
  • About Us
    • Organizational Overview
    • Executive Leadership
    • Governance
    • Our Members
    • Scientific Planning and Review
    • Trial Monitoring
    • Operations
    • Biostatistics and Data Management
    • Collaborations
    • Active Clinical Trials
    • Find a Participating Institution
    • Scientific Achievements
    • Constitution
  • Scientific Programs
    • Cancer Control and Outcomes Program
    • Therapeutic Studies Program
    • Biomarker Sciences Program
  • Research Support
    • Research Support Committees
    • Mentoring Program
    • Training and Education
  • Research Cores
    • Central Biorepository and Pathology Facility
    • Imaging Core Laboratory
    • Leukemia Translational Science Center
    • Thoracic Malignancies Integrated Translational Science Center
  • Resources
    • Active Clinical Trials: Resources
    • Group Meetings
    • Comis Translational Science Symposium
    • NCI-MATCH / EAY131 for Researchers
    • Publications
    • ECOG Performance Status
    • ECOG-ACRIN Sample Tracking System
    • CIRB
    • Medidata Rave®
    • TRIAD™
    • SOAPP
    • PrECOG
    • Related Websites
    • Document Library
  • Patients
    • Myths and Facts
    • External Resources and Links
    • Active Clinical Trials: Resources
  • News and Info
    • Advocacy Blog
    • Member Blog
    • Press Releases
  • Contact Us
    • Donations
    • Locations
    • Office of Communications
    • Find a Participating Institution
    • Principal Investigators
Follow @eaonc

Leukemia Translational Science Center

header image_research support

The integrated Leukemia Translational Science Center (LTSC) generates, coordinates, and leads translational studies in leukemia within the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and across the National Cancer Institute’s National Clinical Trials Network. Through all of its activities (see below), the LTSC expects to transform the standard practice of leukemia care with the development and implementation of personalized diagnostic methods, biomarkers, and therapies.

Leadership

Elisabeth M. Paietta, PhD (Albert Einstein College of Medicine)

Ross L. Levine, MD (Memorial Sloan Kettering Cancer Center)

Ari M. Melnick, MD (Weill Cornell Medical College)

A Central Hub

The LTSC serves as the central hub for studies of ECOG-ACRIN’s Leukemia Laboratory Committee, with the support of its Leukemia Translational Research Laboratory (LTRL) and Leukemia Tissue Bank. Through these initiatives, the LTSC has developed an extensive track record in translational research leadership and implementation of state-of-the-art correlative studies in leukemia biology.

The LTSC is further enhanced through its partnership with the New York Genome Center, which provides access to high-throughput genomics technologies, state-of-the-art genomic platforms, computational resources, and the capability to perform extensive, CLIA-certified, clinical genomics assays.

To maximally accelerate high-quality clinical trials based on the most important science, the LTSC offers an interaction framework that attracts junior and senior clinical investigators, laboratory scientists, computational biologists, biostatisticians, and others. This framework enables these individuals to form synergistic research teams. The LTSC hosts two symposia per year at the spring and fall ECOG-ACRIN group meetings.

Pilot Project Funding

The LTSC provides pilot project funding for cross-disciplinary teams. In support of pilot projects, the LTSC offers an extensive suite of scientific resources, including patient specimens, the LTRL, access to the New York Genome Center, genomic and epigenetic profiling databases, and scientific support. In this way, the LTSC ensures that translational scientific studies are seamlessly integrated into leukemia clinical trials to identify predictors of response/outcome, identify and test novel therapies, and develop innovative correlative studies to assess response to anti-leukemia therapies.

 

 

 

 

 

 

7821
Research Cores
Central Biorepository and Pathology Facility
Imaging Core Laboratory
Leukemia Translational Science Center
Thoracic Malignancies Integrated Translational Science Center
A Leukemia Symposium in Honor of Elisabeth M. Paietta, PhD, Thursday, May 2 from 3:30 – 8:00 PM     Attendees of our Spring 2019 Group Meeting in Boston were invited to attend a special session to honor the exceptional accomplishments and outstanding career of Elisabeth M. Paietta, PhD, who is retiring later this year. Dr. Paietta has served as director of the ECOG-ACRIN Leukemia Translational Research Laboratory and the Leukemia Tissue Bank since 1985.     The symposium featured a special talk celebrating her achievements:     "Elisabeth Paietta: A tireless climber who reached many peaks"   Speaker: Jacob M. Rowe, MD Emeritus Professor of Hemato-Oncology, Technion-Israel Institute of Technology Director, Department of Hematology, Shaare Zedek Medical Center     In the May 2019 issue of the ECOG-ACRIN newsletter, Dr. Paietta discussed the clinical significance of measurable residual disease in acute myeloid leukemia.  

© 2012-2020 ECOG-ACRIN Cancer Research Group. All rights reserved.  |  Disclaimer